Understanding Gastric and Lung Cancers in Diverse Populations

Bioinformatics Core

NIH-funded research University of California at Davis · NIH-11168891

This project helps scientists better understand and find new treatments for gastric and lung cancers, especially in minority communities.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California at Davis NIH-funded
Lab location1 site (Davis, United States)
Project IDNIH-11168891 on NIH RePORTER

What this research studies

Our goal is to create and study many new models of gastric and lung cancers from diverse patient populations. These models, called PDX models, help us test how well different cancer medicines work, both alone and in combinations. We will use advanced computer tools to connect how these medicines affect the models with the unique features of each patient's tumor. This work aims to find more personalized and effective treatments for these cancers.

Who could benefit from this research

Good fit: Patients with gastric or lung cancer, especially those from minority backgrounds, could potentially benefit from the future treatments developed through this research.

Not a fit: Patients without gastric or lung cancer would not directly benefit from this specific research focus.

Why it matters

Potential benefit: If successful, this work could lead to more effective and personalized treatment options for gastric and lung cancers, particularly benefiting minority patients.

How similar studies have performed: Patient-derived xenograft (PDX) models are a well-established tool in cancer research, and this project builds upon existing methods while focusing on diversity and specific cancer types.

Where this research is happening

Davis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.